Development of mouse hepatitis virus and SARS-CoV infectious cDNA constructs.
Identifieur interne : 002998 ( PubMed/Corpus ); précédent : 002997; suivant : 002999Development of mouse hepatitis virus and SARS-CoV infectious cDNA constructs.
Auteurs : R S Baric ; A C SimsSource :
- Current topics in microbiology and immunology [ 0070-217X ] ; 2005.
English descriptors
- KwdEn :
- MESH :
- chemical , genetics : DNA, Complementary.
- genetics : Murine hepatitis virus, SARS Virus, Transmissible gastroenteritis virus.
- Animals, Base Sequence, Genome, Viral, Humans, Mice, Molecular Sequence Data, Recombination, Genetic.
Abstract
The genomes of transmissible gastroenteritis virus (TGEV) and mouse hepatitis virus (MHV) have been generated with a novel construction strategy that allows for the assembly of very large RNA and DNA genomes from a panel of contiguous cDNA subclones. Recombinant viruses generated from these methods contained the appropriate marker mutations and replicated as efficiently as wild-type virus. The MHV cloning strategy can also be used to generate recombinant viruses that contain foreign genes or mutations at virtually any given nucleotide. MHV molecular viruses were engineered to express green fluorescent protein (GFP), demonstrating the feasibility of the systematic assembly approach to create recombinant viruses expressing foreign genes. The systematic assembly approach was used to develop an infectious clone of the newly identified human coronavirus, the serve acute respiratory syndrome virus (SARS-CoV). Our cloning and assembly strategy generated an infectious clone within 2 months of identification of the causative agent of SARS, providing a critical tool to study coronavirus pathogenesis and replication. The availability of coronavirus infectious cDNAs heralds a new era in coronavirus genetics and genomic applications, especially within the replicase proteins whose functions in replication and pathogenesis are virtually unknown.
DOI: 10.1007/3-540-26765-4_8
PubMed: 15609514
Links to Exploration step
pubmed:15609514Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development of mouse hepatitis virus and SARS-CoV infectious cDNA constructs.</title><author><name sortKey="Baric, R S" sort="Baric, R S" uniqKey="Baric R" first="R S" last="Baric">R S Baric</name><affiliation><nlm:affiliation>Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7400, USA. rbaric@email.unc.edu</nlm:affiliation></affiliation></author><author><name sortKey="Sims, A C" sort="Sims, A C" uniqKey="Sims A" first="A C" last="Sims">A C Sims</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15609514</idno><idno type="pmid">15609514</idno><idno type="doi">10.1007/3-540-26765-4_8</idno><idno type="wicri:Area/PubMed/Corpus">002998</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002998</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Development of mouse hepatitis virus and SARS-CoV infectious cDNA constructs.</title><author><name sortKey="Baric, R S" sort="Baric, R S" uniqKey="Baric R" first="R S" last="Baric">R S Baric</name><affiliation><nlm:affiliation>Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7400, USA. rbaric@email.unc.edu</nlm:affiliation></affiliation></author><author><name sortKey="Sims, A C" sort="Sims, A C" uniqKey="Sims A" first="A C" last="Sims">A C Sims</name></author></analytic><series><title level="j">Current topics in microbiology and immunology</title><idno type="ISSN">0070-217X</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Base Sequence</term><term>DNA, Complementary (genetics)</term><term>Genome, Viral</term><term>Humans</term><term>Mice</term><term>Molecular Sequence Data</term><term>Murine hepatitis virus (genetics)</term><term>Recombination, Genetic</term><term>SARS Virus (genetics)</term><term>Transmissible gastroenteritis virus (genetics)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>DNA, Complementary</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Murine hepatitis virus</term><term>SARS Virus</term><term>Transmissible gastroenteritis virus</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Base Sequence</term><term>Genome, Viral</term><term>Humans</term><term>Mice</term><term>Molecular Sequence Data</term><term>Recombination, Genetic</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The genomes of transmissible gastroenteritis virus (TGEV) and mouse hepatitis virus (MHV) have been generated with a novel construction strategy that allows for the assembly of very large RNA and DNA genomes from a panel of contiguous cDNA subclones. Recombinant viruses generated from these methods contained the appropriate marker mutations and replicated as efficiently as wild-type virus. The MHV cloning strategy can also be used to generate recombinant viruses that contain foreign genes or mutations at virtually any given nucleotide. MHV molecular viruses were engineered to express green fluorescent protein (GFP), demonstrating the feasibility of the systematic assembly approach to create recombinant viruses expressing foreign genes. The systematic assembly approach was used to develop an infectious clone of the newly identified human coronavirus, the serve acute respiratory syndrome virus (SARS-CoV). Our cloning and assembly strategy generated an infectious clone within 2 months of identification of the causative agent of SARS, providing a critical tool to study coronavirus pathogenesis and replication. The availability of coronavirus infectious cDNAs heralds a new era in coronavirus genetics and genomic applications, especially within the replicase proteins whose functions in replication and pathogenesis are virtually unknown.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15609514</PMID><DateCompleted><Year>2005</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0070-217X</ISSN><JournalIssue CitedMedium="Print"><Volume>287</Volume><PubDate><Year>2005</Year></PubDate></JournalIssue><Title>Current topics in microbiology and immunology</Title><ISOAbbreviation>Curr. Top. Microbiol. Immunol.</ISOAbbreviation></Journal><ArticleTitle>Development of mouse hepatitis virus and SARS-CoV infectious cDNA constructs.</ArticleTitle><Pagination><MedlinePgn>229-52</MedlinePgn></Pagination><Abstract><AbstractText>The genomes of transmissible gastroenteritis virus (TGEV) and mouse hepatitis virus (MHV) have been generated with a novel construction strategy that allows for the assembly of very large RNA and DNA genomes from a panel of contiguous cDNA subclones. Recombinant viruses generated from these methods contained the appropriate marker mutations and replicated as efficiently as wild-type virus. The MHV cloning strategy can also be used to generate recombinant viruses that contain foreign genes or mutations at virtually any given nucleotide. MHV molecular viruses were engineered to express green fluorescent protein (GFP), demonstrating the feasibility of the systematic assembly approach to create recombinant viruses expressing foreign genes. The systematic assembly approach was used to develop an infectious clone of the newly identified human coronavirus, the serve acute respiratory syndrome virus (SARS-CoV). Our cloning and assembly strategy generated an infectious clone within 2 months of identification of the causative agent of SARS, providing a critical tool to study coronavirus pathogenesis and replication. The availability of coronavirus infectious cDNAs heralds a new era in coronavirus genetics and genomic applications, especially within the replicase proteins whose functions in replication and pathogenesis are virtually unknown.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baric</LastName><ForeName>R S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7400, USA. rbaric@email.unc.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sims</LastName><ForeName>A C</ForeName><Initials>AC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Curr Top Microbiol Immunol</MedlineTA><NlmUniqueID>0110513</NlmUniqueID><ISSNLinking>0070-217X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018076">DNA, Complementary</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="Y">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006517" MajorTopicYN="N">Murine hepatitis virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011995" MajorTopicYN="Y">Recombination, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005760" MajorTopicYN="N">Transmissible gastroenteritis virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>51</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>12</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>2</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>12</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15609514</ArticleId><ArticleId IdType="doi">10.1007/3-540-26765-4_8</ArticleId><ArticleId IdType="pmc">PMC7122489</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature. 1992 Jun 4;357(6377):417-20</Citation><ArticleIdList><ArticleId IdType="pubmed">1350661</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1988 Jun;62(6):2191-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2835520</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1999 Oct;73(10):8349-55</Citation><ArticleIdList><ArticleId IdType="pubmed">10482585</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 1992 Sep;190(1):92-105</Citation><ArticleIdList><ArticleId IdType="pubmed">1326823</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1991 Jun;65(6):3369-73</Citation><ArticleIdList><ArticleId IdType="pubmed">1851885</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1999 Feb;73(2):1535-45</Citation><ArticleIdList><ArticleId IdType="pubmed">9882359</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1998 Dec;72(12):9628-36</Citation><ArticleIdList><ArticleId IdType="pubmed">9811696</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 1998 Feb 1;241(1):112-21</Citation><ArticleIdList><ArticleId IdType="pubmed">9454722</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Adv Virus Res. 1999;53:245-64</Citation><ArticleIdList><ArticleId IdType="pubmed">10582102</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Adv Exp Med Biol. 2001;494:453-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11774507</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Adv Virus Res. 1997;48:1-100</Citation><ArticleIdList><ArticleId IdType="pubmed">9233431</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Gen Virol. 2002 Mar;83(Pt 3):567-579</Citation><ArticleIdList><ArticleId IdType="pubmed">11842252</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>New Biol. 1989 Dec;1(3):285-96</Citation><ArticleIdList><ArticleId IdType="pubmed">2487295</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4873-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10781094</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2001 Oct;75(19):9059-67</Citation><ArticleIdList><ArticleId IdType="pubmed">11533169</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Hum Mol Genet. 1998;7(10):1635-40</Citation><ArticleIdList><ArticleId IdType="pubmed">9735385</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1996 Jul;70(7):4773-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8676505</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2000 May 9;97(10):5516-21</Citation><ArticleIdList><ArticleId IdType="pubmed">10805807</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1994 Nov;68(11):7458-66</Citation><ArticleIdList><ArticleId IdType="pubmed">7933129</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1996 Dec;70(12):8669-74</Citation><ArticleIdList><ArticleId IdType="pubmed">8970993</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2002 Nov;76(21):11065-78</Citation><ArticleIdList><ArticleId IdType="pubmed">12368349</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Arch Virol. 1997;142(3):629-33</Citation><ArticleIdList><ArticleId IdType="pubmed">9349308</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1998 Oct;72(10):7926-33</Citation><ArticleIdList><ArticleId IdType="pubmed">9733830</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2002 Jun;76(12):6257-67</Citation><ArticleIdList><ArticleId IdType="pubmed">12021359</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2002 Feb;76(3):1422-34</Citation><ArticleIdList><ArticleId IdType="pubmed">11773416</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 1999 Dec 10;286(5447):2087, 2089-90</Citation><ArticleIdList><ArticleId IdType="pubmed">10617419</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 1994 Feb;198(2):415-26</Citation><ArticleIdList><ArticleId IdType="pubmed">8291226</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 1991 Feb;180(2):567-82</Citation><ArticleIdList><ArticleId IdType="pubmed">1846489</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Arch Virol. 1999;144(4):763-70</Citation><ArticleIdList><ArticleId IdType="pubmed">10365166</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2001 Dec;75(24):12359-69</Citation><ArticleIdList><ArticleId IdType="pubmed">11711626</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virus Genes. 2001;23(1):105-18</Citation><ArticleIdList><ArticleId IdType="pubmed">11556396</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12995-3000</Citation><ArticleIdList><ArticleId IdType="pubmed">14569023</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 1997 Jan 20;227(2):378-88</Citation><ArticleIdList><ArticleId IdType="pubmed">9018137</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2000 Nov;74(22):10600-11</Citation><ArticleIdList><ArticleId IdType="pubmed">11044104</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2001 Jul;75(14):6676-81</Citation><ArticleIdList><ArticleId IdType="pubmed">11413334</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 1994 Feb;198(2):736-40</Citation><ArticleIdList><ArticleId IdType="pubmed">8291254</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2000 Feb;74(3):1393-406</Citation><ArticleIdList><ArticleId IdType="pubmed">10627550</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vet Microbiol. 1990 Jun;23(1-4):147-54</Citation><ArticleIdList><ArticleId IdType="pubmed">2169670</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1994 Dec;68(12):8169-79</Citation><ArticleIdList><ArticleId IdType="pubmed">7966608</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 1999 Dec 10;286(5447):2165-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10591650</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1999 Sep;73(9):7607-18</Citation><ArticleIdList><ArticleId IdType="pubmed">10438851</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 1992 Jul;189(1):88-102</Citation><ArticleIdList><ArticleId IdType="pubmed">1318616</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1999 Jul;73(7):6128-35</Citation><ArticleIdList><ArticleId IdType="pubmed">10364371</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nucleic Acids Res. 2001 Sep 15;29(18):3705-27</Citation><ArticleIdList><ArticleId IdType="pubmed">11557805</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002998 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002998 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:15609514
|texte= Development of mouse hepatitis virus and SARS-CoV infectious cDNA constructs.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:15609514" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |